<div class="p4l_caption"><div class="p4l_captionTitle"><a target="_blank" href="http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3124358/" ref="ordinalpos=4354&amp;ncbi_uid=3465177&amp;link_uid=PMC3124358" image-link="/pmc/articles/PMC3124358/figure/fig2/" class="imagepopup">Figure 2.  From: Use of Gene Expression and <span class="highlight" style="background-color:">Pathway</span> Signatures to Characterize the Complexity of Human Melanoma. </a></div><br /><div class="p4l_captionBody">The status of oncogenic signaling pathway activities analyzed in the benign nevi, primary melanoma, and metastatic melanoma samples. Within the heat map, columns represent samples; and rows, the oncogenic signaling pathway analyzed. Pathway activities on a low to high continuum are represented by a blue to red continuum, respectively. The color bar below the heatmap defines the sample in each column. The samples are ordered according to the defined subgroups, as shown in Figure 1 (the array tree above the heat map defines the subgroups of melanoma samples exhibiting similar gene expression patterns). CAT indicates catenin; EGFR, epidermal growth factor receptor; ER, estrogen receptor; HER, 2 human epidermal growth factor receptor 2; PI3k, phosphatidylinositol 3-kinase; PR, progesterone receptor.</div></div>